HCA vs. GILD, ZTS, BMY, GSK, MCK, BDX, CI, VRTX, REGN, and BSX
Should you be buying HCA Healthcare stock or one of its competitors? The main competitors of HCA Healthcare include Gilead Sciences (GILD), Zoetis (ZTS), Bristol-Myers Squibb (BMY), GSK (GSK), McKesson (MCK), Becton, Dickinson and Company (BDX), The Cigna Group (CI), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Boston Scientific (BSX). These companies are all part of the "medical" sector.
HCA Healthcare (NYSE:HCA) and Gilead Sciences (NASDAQ:GILD) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, community ranking, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.
HCA Healthcare has a beta of 1.66, suggesting that its share price is 66% more volatile than the S&P 500. Comparatively, Gilead Sciences has a beta of 0.22, suggesting that its share price is 78% less volatile than the S&P 500.
Gilead Sciences has lower revenue, but higher earnings than HCA Healthcare. HCA Healthcare is trading at a lower price-to-earnings ratio than Gilead Sciences, indicating that it is currently the more affordable of the two stocks.
HCA Healthcare pays an annual dividend of $2.64 per share and has a dividend yield of 0.8%. Gilead Sciences pays an annual dividend of $3.08 per share and has a dividend yield of 4.7%. HCA Healthcare pays out 13.2% of its earnings in the form of a dividend. Gilead Sciences pays out 855.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
HCA Healthcare has a net margin of 8.20% compared to Gilead Sciences' net margin of 1.76%. HCA Healthcare's return on equity of 674.49% beat Gilead Sciences' return on equity.
62.7% of HCA Healthcare shares are held by institutional investors. Comparatively, 83.7% of Gilead Sciences shares are held by institutional investors. 1.6% of HCA Healthcare shares are held by insiders. Comparatively, 0.2% of Gilead Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Gilead Sciences received 1252 more outperform votes than HCA Healthcare when rated by MarketBeat users. Likewise, 77.37% of users gave Gilead Sciences an outperform vote while only 77.31% of users gave HCA Healthcare an outperform vote.
HCA Healthcare presently has a consensus price target of $317.00, suggesting a potential downside of 2.95%. Gilead Sciences has a consensus price target of $83.69, suggesting a potential upside of 26.88%. Given Gilead Sciences' higher probable upside, analysts plainly believe Gilead Sciences is more favorable than HCA Healthcare.
In the previous week, HCA Healthcare had 11 more articles in the media than Gilead Sciences. MarketBeat recorded 27 mentions for HCA Healthcare and 16 mentions for Gilead Sciences. Gilead Sciences' average media sentiment score of 0.75 beat HCA Healthcare's score of 0.40 indicating that Gilead Sciences is being referred to more favorably in the news media.
Summary
HCA Healthcare beats Gilead Sciences on 11 of the 20 factors compared between the two stocks.
Get HCA Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HCA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
HCA Healthcare Competitors List
Related Companies and Tools
